Transcranial focused ultrasound as a possible treatment for major depressionAntidepressants are currently used as initial therapies for major depressive disorder (MDD). However, despite the remarkable increase in medications validated as effective in MDD, treatments are still plagued by inadequate responses ...
Today's treatments for depression and anxiety leave much to be desired. Pharmaceuticals may help the symptoms, but they can also have negative side effects like weight gain and decreased sexual desire that may cause people to abandon medication altogether. As cases of depression and anxiety increase...
Ginseng alleviates COVID-19 pandemic-caused depression by targeting inflammasomes Currently, there are no known specific treatments that can inhibit SARS-CoV-2 infection and cure neurological symptoms such as depression caused by the infection. Due to the lack of definitive treatment options, natural ...
When other anxiety treatments have failed, or you want to exhaust every option before you consider medications or therapy, it’s not uncommon to seek out alternative treatments. One option that many consider is hypnotherapy. But does hypnosis for anxiety really work? About Hypnosis and Anxiety Hyp...
However, a large Mendelian randomisa- tion study found no causal association between increased CRP levels and depression in people with genetically ele- vated CRP [108], and also that inflammation may better stratify those who will or will not benefit from anti- inflammatory treatments [109]. ...
The patient achieved depression remission through 39 sessions of high-frequency left dorsolateral prefrontal cortex rTMS treatments. We assessed disease progression using the Quick Inventory of Depressive Symptomatology, and we measured blood pressure before each session of rTMS. After ...
The role of orexin in post-stroke inflammation, cognitive decline, and depression Moderate hyperglycemia worsens acute blood–brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24(1):111–6. Tatemichi TK, Desmond DW, ... J Song,E Kim,CH Kim,... - 《Molecular Brain》 被...
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments. Neurosci Biobehav Rev. 2017;75:157–65. Article CAS PubMed Google Scholar Vallée A, Lecarpentier Y, Guillevin R, Vallée J-N. Effects of cannabidiol interactions with ...
"There are several drugs used to treat depression, anxiety, epilepsy and aggression in people with Fragile X. Most of these drugs have many side effects. Similarly, for Phelan McDermid syndrome, current treatments mostly target epilepsy and anxiety. There has been limited research on this conditio...
What is more 30–50% of patients do not respond to available treatments [37], displaying the "treatment resistant" phenotype. One possible explanation for the limited efficacy of anti- depressants is that their mechanism of action involves elevat- ing monoamine levels. However, people with ...